Hace casi un mes, el pueblo venezolano votó por Edmundo González Urrutia como su presidente electo. Ayer, el Tribunal Supremo de Justicia del narco-régimen de Maduro optó por legitimar el fraude electoral de la dictadura. Los senadores estadounidenses Marco Rubio...
News
Latest News
Rubio, Colleagues: This is Not About Political Ideology, This is About Defending the Will of the Venezuelan People
Almost one month ago, the Venezuelan people voted for Edmundo González Urrutia as their president-elect. Yesterday, the Maduro narco-regime’s Supreme Tribunal of Justice opted to legitimize the dictatorship’s electoral fraud. U.S. Senators Marco Rubio (R-FL),...
Next Week: Rubio Staff Hosts Mobile Office Hours
U.S. Senator Marco Rubio’s (R-FL) office will host in-person Mobile Office Hours next week to assist constituents with federal casework issues in their respective local communities. These office hours offer constituents who do not live close to one of Senator Rubio’s...
Rubio, Díaz-Balart to Biden Admin: Members of the Cuban Regime Are Not Allowed in the U.S.
Recently, a high-ranking member of the Cuban Communist Party, Manuel Menendez Castellanos, was granted entry into the United States through the Miami International Airport. Current immigration law prohibits members of communist parties from entering the United States....
Rubio-Warner Statement on Foreign Influence Efforts
Vice Chairman of the Senate Select Committee on Intelligence Marco Rubio (R-FL) and Chairman Mark R. Warner (D-VA) released a statement on apparent efforts by foreign adversaries to influence the United States’ upcoming presidential election: “With less than 100 days...
Rubio, Scott Introduce Resolution Condemning Cuban Regime
The illegitimate Cuban regime has made Cuba a safe haven for Communist China, Russia, Iran, and Venezuela. This poses a direct threat, just 90 miles from our shores, to our national security interests, and the stability of our region. The United States must continue...
ICYMI: Rubio: China is Targeting America’s Biomed Industry
China is targeting America’s biomed industry
By U.S. Senator Marco Rubio
September 21, 2019
Modern Healthcare
Time after time, Americans have watched our nation’s leaders—in politics, academia and the private sector—invest in and open our markets to China with little concern for long-term consequences. When it comes to the threat China poses to the U.S. healthcare industry, we cannot afford to be complacent.
While consumers may have initially welcomed the influx of inexpensive Chinese goods, such as generic drugs and antibiotics, the ultimate price is paid by U.S. manufacturers, who are undercut by China’s cheap labor and forced to shutter. Beijing will continue to undermine America’s withering industries by blatantly stealing our companies’ intellectual property and subsidizing state firms to undercut our competitive edge. China’s goal is market dominance.
…
If we fail to prevent Chinese genomic dominance, how might the future look? Our dependence on Beijing for antibiotics and other drugs, recently flagged by the Pentagon, is instructive. The Chinese have used their command in the pharmaceutical industry as a bargaining chip in tariff negotiations. As the sole makers of some of our military’s drugs, they wield an additional source of leverage in the case of future conflict.
If you find yourself in a hole, the first step is to stop digging. We must immediately enact stricter guidelines for federal policies to guarantee that public funding never contributes to Chinese genomics efforts and then ensure our R&D in this critical area is not eclipsed by China. I have written to HHS’ OIG to voice concerns and submitted several National Defense Authorization Act amendments to this end. I am also developing a unified strategy to protect Americans’ genomic data. Beijing blocks its citizens’ DNA from being shared or stored outside China because they know the data’s value. Why don’t we consider similar measures to prevent others from benefiting from Americans’ DNA?
Chinese domination of the genomics industry poses an extraordinary danger to Americans; medical professionals, healthcare executives and policymakers alike must recognize the extent of the threat. Failure to do so will put our nation’s well-being at risk.
Read more here.